Early data suggested that then-practiced forms of HSCT were very effective only in the short term.  However later study data had most patients thriving, with no relapses within 5 years.  References [ edit ] ^ a b Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, Traboulsee AL, Waters P, Wellik KE, Weinshenker BG (July 2015). "International consensus diagnostic criteria for neuromyelitis optica spectrum disorders" . ... Neurochem Res. 2013;38(5):997-1001. doi:10.1007/s11064-013-1009-0 ^ a b c Wingerchuk, Dean (2006). "Neuromyelitis Optica (Devic's Syndrome)" (PDF) . 2006 Rare Neuroimmunologic Disorders Symposium . ... Trends in Molecular Medicine . 7 (3): 115–21. doi : 10.1016/s1471-4914(00)01909-2 . PMID 11286782 . ^ Iorio R, Rindi G, Erra C, Damato V, Ferilli M, Sabatelli M (May 2015). ... PMID 16831964 . ^ Matiello M, Jacob A, Wingerchuk DM, Weinshenker BG (June 2007). "Neuromyelitis optica".